期刊的影响因子--文章列表

期刊文章列表
Yubo Wang¹，Jian Min²，Xiangping Deng¹，Tian Feng¹，Hebing Hu²，Xinyi Guo¹，Yan Cheng¹，Baohua Xie¹，Yu Yang²，Chun-Chi Chen²，Rey-Ting Guo²，Chune Dong^1,3，Hai-Bing Zhou^1,3,4（Department of Gynecological Oncology，Zhongnan Hospital of Wuhan University，School of Pharmaceutical Sciences，Wuhan University；State Key Laboratory of Biocatalysis and Enzyme Engineering，National&Local Joint Engineering Research Center of High-throughput Drug Screening Technology，Hubei Key Laboratory of Industrial Biotechnology，School of Life Sciences，Hubei University；Frontier Science Center for Immunology and Metabolism，State Key Laboratory of Virology，Provincial Key Laboratory of Developmentally Originated Disease，Key Laboratory of Combinatorial Biosynthesis and Drug Discovery(MOE)and Hubei Province Engineering and Technology Research Center for Fluorinated Pharmaceuticals，Wuhan University；Wuhan Research Center for Infectious Diseases and Cancer，Chinese Academy of Medical Sciences，Zhongnan Hospital of Wuhan University）.Discovery of novel covalent selective estrogen receptor degraders against endocrine-resistant breast cancer[J].Acta Pharmaceutica Sinica B,2023,第12期 Kaikai Zhang¹，Lijian Chen¹，Jianzheng Yang¹，Jiali Liu¹，Jiahao Li¹，Yi Liu¹，Xiuwen Li¹，Long Chen¹，Clare Hsu¹，Jiahao Zeng¹，Xiaoli Xie²，Qi Wang¹（Guangzhou Key Laboratory of Forensic Multi-Omics for Precision Identification，School of Forensic Medicine，Southern Medical University；Department of Toxicology，School of Public Health，Southern Medical University(Guangdong Provincial Key Laboratory of Tropical Disease Research)）.Gut microbiota-derived short-chain fatty acids ameliorate methamphetamine-induced depression- and anxiety-like behaviors in a Sigmar-1 receptor-dependent manner[J].Acta Pharmaceutica Sinica B,2023,第12期 Xintong Zhao，Jing Feng，Jie Zhang，Zunsheng Han，Yuhua Hu，Hui-Hui Shao，Tianlei Li，Jie Xia，Kangfan Lei，Weiping Wang，Fangfang Lai，Yuan Lin，Bo Liu，Kun Zhang，Chi Zhang，Qingyun Yang，Xinyu Luo，Hanyilan Zhang，Chuang Li，Wenxuan Zhang，Song Wu（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College）.Discovery and druggability evaluation of pyrrolamide-type GyrB/ParE inhibitor against drug-resistant bacterial infection[J].Acta Pharmaceutica Sinica B,2023,第12期 Youchao Deng¹，Xiaosheng Song²，Iredia D.Iyamu¹，Aiping Dong²，Jinrong Min^2,3，Rong Huang¹（Department of Medicinal Chemistry and Molecular Pharmacology，Center for Cancer Research，Institute for Drug Discovery，Purdue University；Structural Genomics Consortium and Department of Physiology，University of Toronto；Hubei Key Laboratory of Genetic Regulation and Integrative Biology，School of Life Sciences，Central China Normal University）.A unique binding pocket induced by a noncanonical SAH mimic to develop potent and selective PRMT inhibitors[J].Acta Pharmaceutica Sinica B,2023,第12期 Peng Hua¹，Ruifeng Liang¹，Yanbei Tu¹，Yuying Yin¹，Man-Kay Law²，Meiwan Chen¹（State Key Laboratory of Quality Research in Chinese Medicine，Institute of Chinese Medical Sciences，University of Macau；State Key Laboratory of Analog and Mixed-Signal VLSI，IME and FST-ECE，University of Macau）.Reactive oxygen species and nitric oxide scavenging nanoparticles alleviating rheumatoid arthritis through adjusting the seeds and growing soils[J].Acta Pharmaceutica Sinica B,2023,第12期 Shixin Duan，Xinyi Lou，Shiyi Chen，Hongchao Jiang，Dongxin Chen，Rui Yin，Mengkai Li，Yuseng Gou，Wenjuan Zhao，Lei Sun，Feng Qian（Shanghai Frontiers Science Center of Drug Target Identification and Delivery，National Key Laboratory of Innovative Immunotherapy，Engineering Research Center of Cell＆Therapeutic Antibody，Ministry of Education，School of Pharmacy，Shanghai Jiao Tong University）.Macrophage LMO7 deficiency facilitates inflammatory injury via metabolic-epigenetic reprogramming[J].Acta Pharmaceutica Sinica B,2023,第12期 Feng Long¹，Yao Pan¹，Jinheng Li¹，Suinan Sha¹，Xiubo Shi¹，Haoyan Guo¹，Chuanqing Huang¹，Qian Xiao¹，Chao Fan¹，Xingmei Zhang²，Jun-Bing Fan¹，Ying Wang¹（Cancer Research Institute，Experimental Education/Administration Center，Key Laboratory of Functional Proteomics of Guangdong Province，School of Basic Medical Sciences，Southern Medical University；Department of Neurobiology，School of Basic Medical Sciences，Southern Medical University）.Orange-derived extracellular vesicles nanodrugs for efficient treatment of ovarian cancer assisted by transcytosis effect[J].Acta Pharmaceutica Sinica B,2023,第12期 Yan Zhang¹，Haiyun Zhang²，Faquan Zhao²，Zhengping Jiang¹，Yuanlu Cui²，Meitong Ou¹，Lin Mei¹，Qiangsong Wang¹（Tianjin Key Laboratory of Biomedical Materials，Institute of Biomedical Engineering，Chinese Academy of Medical Sciences&Peking Union Medical College；State Key Laboratory of Component-based Chinese Medicine，Research Center of Traditional Chinese Medicine，Tianjin University of Traditional Chinese Medicine）.Mitochondrial-targeted and ROS-responsive nanocarrier via nose-to-brain pathway for ischemic stroke treatment[J].Acta Pharmaceutica Sinica B,2023,第12期 Xiaodi Liu^1,2，Qi Zhang^2,3，Yixia Liang³，Shiyu Xiong²，Yan Cai，Jincheng Cao²，Yanni Xu²，Xiaolin Xu²，Ye Wu²，Qiang Lu¹，Xiaoding Xu^2,3，Baoming Luo²（Department of Ultrasound，Laboratory of Ultrasound Imaging and Drug，West China Hospital，Sichuan University；Department of Ultrasound，Sun Yat-sen Memorial Hospital，Sun Yat-sen University；Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation，Sun Yat-sen Memorial Hospital，Sun Yat-sen University；Department of Ultrasound，Central People’s Hospital of Zhanjiang）.Nanoparticles（NPs）-mediated Siglec15 silencing and macrophage repolarization for enhanced cancer immunotherapy[J].Acta Pharmaceutica Sinica B,2023,第12期 Jing Ye¹，Jin Zhang¹，Yanghui Zhu¹，Lian Wang^1,2，Xian Jiang¹，Bo Liu¹，Gu He^1,2（Department of Dermatology，State Key Laboratory of Biotherapy，West China Hospital，Sichuan University；Laboratory of Dermatology，Clinical Institute of Inflammation and Immunology(CIII)，Frontiers Science Center for Disease Related Molecular Network）.Targeting autophagy and beyond：Deconvoluting the complexity of Beclin-1 from biological function to cancer therapy[J].Acta Pharmaceutica Sinica B,2023,第12期 Yingqiang Liu¹，Zhengsheng Zhan²，Zhuang Kang³，Mengyuan Li¹，Yongcong Lv²，Shenglan Li³，Linjiang Tong¹，Fang Feng¹，Yan Li¹，Mengge Zhang^1,4，Yaping Xue^1,4,5，Yi Chen^1,4，Tao Zhang¹，Peiran Song^1,6，Yi Su¹，Yanyan Shen¹，Yiming Sun¹，Xinying Yang¹，Yi Chen¹，Shanyan Yao²，Hanyu Yang⁷，Caixia Wang⁷，Meiyu Geng^1,4，Wenbin Li³，Wenhu Duan²，Hua Xie^1,6,4,5，Jian Ding^1,4,5（Division of Antitumor Pharmacology，State Key Laboratory of Drug Research，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；Department of Medicinal Chemistry，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；Department of Neuro-oncology，Cancer Center，Beijing Tiantan Hospital，Capital Medical University；University of Chinese Academy of Sciences；Hangzhou Institute for Advanced Study，University of Chinese Academy of Sciences；Zhongshan Institute for Drug Discovery，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；Shanghai Runshi Pharmaceutical Technology Co.Ltd.）.Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood-brain barrier and exhibits potent activity against glioblastoma[J].Acta Pharmaceutica Sinica B,2023,第12期 Xuesong Li¹，Xiang Chen¹，Longbin Zheng^1,2，Minghong Chen¹，Yunjia Zhang¹，Ruigong Zhu¹，Jiajing Chen³，Jiaming Gu¹，Quanwen Yin¹，Hong Jiang¹，Xuan Wu¹，Xian Ji¹，Xin Tang¹，Mengdie Dong¹，Qingguo Li⁴，Yuanqing Gao¹，Hongshan Chen^1,4,5,6（Key Laboratory of Cardiovascular and Cerebrovascular Medicine，School of Pharmacy，Nanjing Medical University；Department of Anesthesiology，Sir Run Run Hospital，Nanjing Medical University；Department of Pharmacy，Huashan Hospital，Fudan University；Department of Cardiothoracic Surgery，the Second Affiliated Hospital of Nanjing Medical University；Key Laboratory of Targeted Intervention of Cardiovascular Disease，Collaborative Innovation Center for Cardiovascular Disease Translational Medicine，Nanjing Medical University；Department of Cardiology，Huai'an First People's Hospital Affiliated with Nanjing Medical University）.Non-canonical STING-PERK pathway dependent epigenetic regulation of vascular endothelial dysfunction via integrating IRF3 and NF-κB in inflammatory response[J].Acta Pharmaceutica Sinica B,2023,第12期 Lina Guo¹，Jinsong Ding¹，Wenhu Zhou^1,2（Xiangya School of Pharmaceutical Sciences，Central South University；Key Laboratory of Biological Nanotechnology of National Health Commission，Xiangya Hospital）.Converting bacteria into autologous tumor vaccine via surface biomineralization of calcium carbonate for enhanced immunotherapy[J].Acta Pharmaceutica Sinica B,2023,第12期 Qiaozi Wang^1,2，Yanan Song^1,2，Jinfeng Gao^1,2，Qiyu Li^1,2，Jing Chen^1,2，Yifang Xie³，Zhengmin Wang^1,2，Haipeng Tan^1,2，Hongbo Yang^1,2，Ning Zhang^1,2，Juying Qian^1,2，Zhiqing Pang⁴，Zheyong Huang^1,2，Junbo Ge^1,3,2（Department of Cardiology，Zhongshan Hospital，Fudan University，Shanghai Institute of Cardiovascular Diseases；National Clinical Research Center for Interventional Medicine；Institute of Biomedical Sciences，Fudan University；School of Pharmacy，Fudan University，Key Laboratory of Smart Drug Delivery，Ministry of Education）.Hippo pathway-manipulating neutrophil-mimic hybrid nanoparticles for cardiac ischemic injury via modulation of local immunity and cardiac regeneration[J].Acta Pharmaceutica Sinica B,2023,第12期 Jia-Luo Huang¹，Xue-Long Yan^1,2，Dong Huang¹，Lu Gan¹，Huahua Gao¹，Run-Zhu Fan¹，Shen Li¹，Fang-Yu Yuan¹，Xinying Zhu¹，Gui-Hua Tang¹，Hong-Wu Chen³，Junjian Wang¹，Sheng Yin¹（School of Pharmaceutical Sciences，Sun Yat-sen University；School of Pharmacy，Guizhou Medical University；School of Medicine，University of California Davis）.Discovery of a highly potent and orally available importin-β1 inhibitor that overcomes enzalutamide-resistance in advanced prostate cancer[J].Acta Pharmaceutica Sinica B,2023,第12期 Wenjing Yu^1,2，Yuehuai Hu^1,2，Zhiping Liu³，Kaiteng Guo¹，Dinghu Ma¹，Mingxia Peng¹，Yuemei Wang¹，Jing Zhang¹，Xiaolei Zhang¹，Panxia Wang¹，Jiguo Zhang⁴，Peiqing Liu^1,2,4，Jing Lu^1,2（National and Local United Engineering Lab of Druggability and New Drugs Evaluation，School of Pharmaceutical Sciences，Sun Yat-sen University；Guangdong Provincial Key Laboratory of New Drug Design and Evaluation，Guangdong Province Engineering Laboratory for Druggability and New Drug Evaluation，School of Pharmaceutical Sciences，Sun Yat-sen University；School of Pharmacy，Jinan University；School of Pharmaceutical Sciences，Shandong First Medical University&Shangdong Academy of Medical Sciences）.Sorting nexin 3 exacerbates doxorubicin-induced cardiomyopathy via regulation of TFRC-dependent ferroptosis[J].Acta Pharmaceutica Sinica B,2023,第12期 Chuanfeng Liu¹，Lide Hu¹，Guanyu Dong¹，Ying Zhang¹，Edeildo Ferreira da Silva-Júnior²，Xinyong Liu¹，Luis Menéndez-Arias³，Peng Zhan¹（Department of Medicinal Chemistry，Key Laboratory of Chemical Biology(Ministry of Education)，School of Pharmaceutical Sciences，Shandong University；Laboratory of Medicinal Chemistry，Institute of Pharmaceutical Sciences，Federal University of Alagoas；Centro de Biología Molecular“Severo Ochoa”(Consejo Superior de Investigaciones Científicas&Universidad Autónoma de Madrid)）.Emerging drug design strategies in anti-influenza drug discovery[J].Acta Pharmaceutica Sinica B,2023,第12期 Li-Min Zhao^1,2,3，Christophe Pannecouque⁴，Erik De Clercq⁴，Shuai Wang^2,3，Fen-Er Chen^1,2,3（Key Laboratory of Natural Resources of Changbai Mountain&Functional Molecules，Ministry of Education，Yanbian University College of Pharmacy，Yanbian University；Engineering Center of Catalysis and Synthesis for Chiral Molecules，Department of Chemistry，Fudan University；Shanghai Engineering Center of Industrial Asymmetric Catalysis for Chiral Drugs；Rega Institute for Medical Research）.Structure-based design of novel heterocycle-substituted ATDP analogs as non-nucleoside reverse transcriptase inhibitors with improved selectivity and solubility[J].Acta Pharmaceutica Sinica B,2023,第12期 Huaqing Jing¹，Yingzi Ren¹，Yue Zhou¹，Min Xu¹，Sona Krizkova²，Zbynek Heger²，Qiang Lu¹，Siyu Wang¹，Xiaoyang Liang¹，Vojtech Adam²，Nan Li¹（Tianjin Key Laboratory of Drug Delivery&High-Efficiency，School of Pharmaceutical Science and Technology，Tianjin University；Department of Chemistry and Biochemistry，Mendel University in Brno）.Remodeling of the liver fibrosis microenvironment based on nilotinib-loaded multicatalytic nanozymes with boosted antifibrogenic activity[J].Acta Pharmaceutica Sinica B,2023,第12期 Qiujun Qiu¹，Sunhui Chen²，Huining He³，Jixiang Chen¹，Xinyi Ding¹，Dongdong Wang¹，Jiangang Yang¹，Pengcheng Guo¹，Yang Li¹，Jisu Kim¹，Jianyong Sheng¹，Chao Gao^1,4，Bo Yin⁵，Shihao Zheng⁶，Jianxin Wang^1,7（Department of Pharmaceutics，School of Pharmacy，Fudan University&Key Laboratory of Smart Drug Delivery，Ministry of Education；Department of Pharmacy，Fujian Provincial Hospital&Provincial Clinical Medical College of Fujian Medical University；Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics，School of Pharmacy，Tianjin Medical University；Institute of Tropical Medicine，Guangzhou University of Chinese Medicine；Department of Radiology，Huashan Hospital，Fudan University；Department of Neurosurgery，Fujian Provincial Hospital&Provincial Clinical Medical College of Fujian Medical University；Institute of Materia Medica，Academy of Chinese and Western Integrative Medicine，Fudan University）.An injectable signal-amplifying device elicits a specific immune response against malignant glioblastoma[J].Acta Pharmaceutica Sinica B,2023,第12期 Junting Zhang^1，3，Yiying Li^1，3，Jianchao Zhang^1，3，Lu Liu⁴，Yuan Chen⁵，Xusheng Yang⁵，Xueyi Liao^1，3，Muhua He⁴，Zihui Jia⁵，Jun Fan⁶，Jin-Song Bian⁴，Xiaowei Nie^1，3（Shenzhen Institute of Respiratory Disease，Shenzhen Key Laboratory of Respiratory Disease，Shenzhen People’s Hospital(the Second Clinical Medical College，Jinan University；the First Affiliated Hospital，Southern University of Science and Technology)；Post-Doctoral Scientific Research Station of Basic Medicine，Jinan University；Department of Pharmacology，School of Medicine，Southern University of Science and Technology；Lung Transplant Group，Wuxi People’s Hospital Affiliated to Nanjing Medical University；Department of Medical Biochemistry and Molecular Biology，School of Medicine，Jinan University）.ADAR1 regulates vascular remodeling in hypoxic pulmonary hypertension through N1-methyladenosine modification of circCDK17[J].Acta Pharmaceutica Sinica B,2023,第12期 Wenjun Yu^1,2,3,4，Haixia Xu^1,2,5，Zhe Sun^1,2，Yuxin Du^1,2，Shiqun Sun^1,2，Miyesaier Abudureyimu^2,6，Mengjiao Zhang^1,2，Jun Tao⁷，Junbo Ge^1,2，Jun Ren^1,2，Yingmei Zhang^1,2（Department of Cardiology and Shanghai Institute of Cardiovascular Diseases，Zhongshan Hospital，Fudan University；National Clinical Research Center for Interventional Medicine；Department of Cardiovascular Surgery，Zhongnan Hospital of Wuhan University；Hubei Provincial Engineering Research Center of Minimally Invasive Cardiovascular Surgery；Department of Cardiology，Affiliated Hospital of Nantong University；Cardiovascular Department，Shanghai Xuhui Central Hospital，Zhongshan-Xuhui Hospital，Fudan University；Department of Cardiovascular Surgery，Sun Yat-sen Memorial Hospital，Sun Yat-sen University）.TBC1D15 deficiency protects against doxorubicin cardiotoxicity via inhibiting DNA-PKcs cytosolic retention and DNA damage[J].Acta Pharmaceutica Sinica B,2023,第12期 Mingjin Wang，Weida Wang，Shen You，Zhenyan Hou，Ming Ji，Nina Xue，Tingting Du，Xiaoguang Chen，Jing Jin（Department of Pharmacology，State Key Laboratory of Bioactive Substances and Functions of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College）.ACAT1 deficiency in myeloid cells promotes glioblastoma progression by enhancing the accumulation of myeloid-derived suppressor cells[J].Acta Pharmaceutica Sinica B,2023,第12期 Yanping Wang¹，Weihong Du²，Xiaoyan Hu²，Xin Yu³，Chun Guo⁴，Xinchun Jin²，Wei Wang⁵（Department of Neurology，the Second Affiliated Hospital of Jiaxing City；Beijing Key Laboratory of Cancer Invasion and Metastasis Research，Department of Histology and Embryology，School of Basic Medical Sciences，Advanced Innovation Center for Human Brain Protection，Capital Medical University；Bengbu Medical College(Department of Neurology，the Second Hospital of Jiaxing City)；School of Biosciences，University of Sheffield；Department of Physiology and Pathophysiology，Capital Medical University）.Targeting the blood-brain barrier to delay aging-accompanied neurological diseases by modulating gut microbiota, circadian rhythms,and their interplays[J].Acta Pharmaceutica Sinica B,2023,第12期 Yongho Jang¹，Jeehun Park²，Pilsu Kim³，Eun-Joo Park⁴，Hyungjin Sun⁵，Yujin Baek⁶，Jaehun Jung¹，Tai-kyong Song³，Junsang Doh^2,6,7，Hyuncheol Kim^1,8（Department of Chemical and Biomolecular Engineering，Sogang University；Research Institute of Advanced Materials(RIAM)，Institute of Engineering Research，Seoul National University；Department of Electronic Engineering，Sogang University；Biomedical Research Institute&Department of Radiology，Seoul National University Hospital；Interdisciplinary Program in Bioengineering，Seoul National University；Department of Materials Science and Engineering，Seoul National University；Institute of Engineering Research，Bio-MAX Institute，Seoul National University；Department of Biomedical Engineering，Sogang University）.Development of exosome membrane materials-fused microbubbles for enhanced stability and efficient drug delivery of ultrasound contrast agent[J].Acta Pharmaceutica Sinica B,2023,第12期 Yong Ke¹，En Zhang^2,3，Jianming Guo^2,3，Xiaoxiao Zhang^2,3，Lei Wang¹，Duo Chen^2,3，Xinkui Fang²，Jianwei Zhu¹，Feng Li⁴，Tao Sun^2,3，Baohong Zhang¹（Engineering Research Center of Cell&Therapeutic Antibody，Ministry of Education，School of Pharmacy，Shanghai Jiao Tong University；School of Agriculture and Biology，Shanghai Jiao Tong University；Shanghai Municipal Veterinary Key Laboratory；Shanghai Public Health Clinical Center，Fudan Univeristy）.Immunogenicity of mucosal COVID-19 vaccine candidates based on the highly attenuated vesicular stomatitis virus vector(VSV_MT) in golden syrian hamster[J].Acta Pharmaceutica Sinica B,2023,第12期 Feifei Fang¹，Yang Dai²，Hao Wang^3,4，Yinchun Ji²，Xuewu Liang^2,4，Xia Peng²，Jiyuan Li²，Yangrong Zhao²，Chunpu Li^2,4，Danyi Wang^2,4，Yazhou Li²，Dong Zhang²，Dan Zhang²，Meiyu Geng^2,4,5,6，Hong Liu^2,4,6，Jing Ai^2,4,6，Yu Zhou^3,4,6（Lingang Laboratory；State Key Laboratory of Drug Research，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；Drug Discovery&Development Center，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；University of Chinese Academy of Sciences；Shandong Laboratory of Yantai Drug Discovery，Bohai Rim Advanced Research Institute for Drug Discovery；School of Pharmaceutical Science and Technology，Hangzhou Institute for Advanced Study，UCAS）.Structure-based drug discovery of novel fused-pyrazolone carboxamide derivatives as potent and selective AXL inhibitors[J].Acta Pharmaceutica Sinica B,2023,第12期 Yitong Liu^1,2，Guiyang Xia³，Yingyi Chen^1,2，Huan Xia³，Junji Xu^1,2，Lijia Guo⁴，Sheng Lin³，Yi Liu^1,2（Laboratory of Tissue Regeneration and Immunology and Department of Periodontics，Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction，School of Stomatology，Capital Medical University；Immunology Research Center for Oral and Systemic Health，Beijing Friendship Hospital，Capital Medical University；Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing，Dongzhimen Hospital，Beijing University of Chinese Medicine；Department of Orthodontics，School of Stomatology，Capital Medical University）.Purpurolide C-based microneedle promotes macrophage-mediated diabetic wound healing via inhibiting TLR4-MD2 dimerization and MYD88 phosphorylation[J].Acta Pharmaceutica Sinica B,2023,第12期首页 1 2 3 4 5 下一页尾页共有11页，转到页

期刊文章列表